NCT03214874View on ClinicalTrials.gov

Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

July 20, 2017

Study Completion Date

July 20, 2017

Conditions
Congestive Heart FailureChronic Kidney Diseases
Interventions
DRUG

Demadex 20mg Tablet

Immediate Release (IR) Torsemide

DRUG

ER Torsemide 20mg Tablet

Extended Release Torsemide 20 mg tablet given once daily

Trial Locations (1)

Unknown

I.E.C. Consultants, Bangalore

All Listed Sponsors
lead

Sarfez Pharmaceuticals, Inc.

INDUSTRY

NCT03214874 - Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects | Biotech Hunter | Biotech Hunter